| Literature DB >> 24119509 |
Amy Wang, Subhas Banerjee, Bradley A Barth, Yasser M Bhat, Shailendra Chauhan, Klaus T Gottlieb, Vani Konda, John T Maple, Faris Murad, Patrick R Pfau, Douglas K Pleskow, Uzma D Siddiqui, Jeffrey L Tokar, Sarah A Rodriguez.
Abstract
Over the last decade, WCE has established itself as a valuable test for imaging the small intestine. It is a safe and relatively easy procedure to perform that can provide valuable information in the diagnosis of small-bowel conditions. Its applications still remain limited within the esophagus and colon. Future developments may include improving visualization within the esophagus and developing technologies that may allow manipulation of the capsule within the GI tract and biopsy capabilities.Entities:
Keywords: DBE; FDA; Food and Drug Administration; NSAID; OGIB; WCE; double-balloon endoscopy; nonsteroidal anti-inflammatory drug; obscure GI bleeding; wireless capsule endoscopy
Mesh：
Year: 2013 PMID： 24119509 DOI： 10.1016/j.gie.2013.06.026
Source DB: PubMed Journal: Gastrointest Endosc ISSN： 0016-5107 Impact factor: 9.427